Citation Impact
Citing Papers
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Supplemental and Complementary Alternatives to Hormone Replacement Therapy
1999
The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.
1993
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
2003 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
Health benefits of physical activity: the evidence
2006 Standout
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Osteoporosis
2019 Standout
Regulation of the Voltage Gated K<sup>+</sup> Channel K<sub>v1.3</sub> by Recombinant Human Klotho Protein
2014 Standout
Osteoporosis Prevention and Treatment
1996
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women
2000
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
Bone mineral density measured by dual-energy X-ray absorptiometry in healthy finnish women
1991
Calcium and osteoporosis
1997
Dietary Polyphenols and the Prevention of Diseases
2005 Standout
Pathogenesis of osteoporosis
2003
Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change
2003 Standout
Combination Treatment with Estrogen and Calcitriol in the Prevention of Age-Related Bone Loss
2001
Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post‐menopausal osteoporosis
1994
VI. Meta-Analysis of Calcitonin for the Treatment of Postmenopausal Osteoporosis
2002
Vitamin D Deficiency
2007 Standout
Inhibition of parathyroid hormone-stimulated resorption in cultured fetal rat long bones by the main metabolites of ipriflavone
1996
Inhibitory effect of ipriflavone on osteoclast-mediated bone resorption and new osteoclast formation in long-term cultures of mouse unfractionated bone cells
1993
Legumes and soybeans: overview of their nutritional profiles and health effects
1999 Standout
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
2006 Standout
Bone-sparing effect of soy protein in ovarian hormone–deficient rats is related to its isoflavone content
1998
Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome
1992
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
1992 Standout
Phyto-oestrogens and Western Diseases
1997 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Osteoporosis: now and the future
2011 Standout
Effect of calcitonin on bone mass and fracture rates
1991
Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent Fractures
2004
Skeletal remodeling in health and disease
2007 Standout
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
2006 Standout
Flavonoids: Old and new aspects of a class of natural therapeutic drugs
1999 Standout
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen
1992
V. Meta-Analysis of the Efficacy of Hormone Replacement Therapy in Treating and Preventing Osteoporosis in Postmenopausal Women
2002
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
Effects of Age and Estrogen Status on Serum Parathyroid Hormone Levels and Biochemical Markers of Bone Turnover in Women: A Population-Based Study1
1997
Effect of Vitamin D on Falls
2004 Standout
Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer
1992
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report
1994 Standout
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Estrogen Preserves a Normal Intestinal Responsiveness to 1,25-Dihydroxyvitamin D3in Oophorectomized Women*
1990
Production and Actions of Estrogens
2002 Standout
A Comparative Study on Phenolic Profiles and Antioxidant Activities of Legumes as Affected by Extraction Solvents
2007 Standout
Dietary Soybean Protein Prevents Bone Loss in an Ovariectomized Rat Model of Osteoporosis
1996
Human parathyroid peptide treatment of vertebral osteoporosis
1993
1,25-Dihydroxyvitamin D3-Independent Stimulatory Effect of Estrogen on the Expression of ECaC1 in the Kidney
2002
Transformational, transactional, and laissez-faire leadership styles: A meta-analysis comparing women and men.
2003 Standout
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Trabecular and endocortical bone remodeling in postmenopausal osteoporosis: Comparison with normal postmenopausal women
1990
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene
2002
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Vertebral fracture assessment using a semiquantitative technique
1993 Standout
Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis
2000 Standout
Biochemical Markers of Bone Turnover for the Clinical Assessment of Metabolic Bone Disease
1990
Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause--a clinical research center study.
1995
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
TREATMENT OF OSTEOPOROSIS
1995
Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass
1994
Pretreatment Levels of Bone Turnover and the Antifracture Efficacy of Alendronate: The Fracture Intervention Trial
2006
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Treatment of osteoporosis.
1967
Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis
1996
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Biochemical markers of bone turnover in osteoporosis.
1997
The bone-remodeling transient: Implications for the interpretation of clinical studies of bone mass change
1994
Bone metabolism and disease in chronic kidney disease
2003
Interventions for preventing falls in older people living in the community
2012 Standout
Population-Based Study of Age and Sex Differences in Bone Volumetric Density, Size, Geometry, and Structure at Different Skeletal Sites
2004 Standout
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Works of F Zacchei being referenced
Effects of one-year treatment with estrogens on bone mass, intestinal calcium absorption, and 25-hydroxyvitamin D-1α-hydroxylase reserve in postmenopausal osteoporosis
1988
Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
1988
Metabolic and clinical effects of ipriflavone in established post-menopausal osteoporosis.
1989